ロード中...
Pilot study of radiofrequency hyperthermia in combination with gefitinib in gefitinib‐effective patients with advanced NSCLC
BACKGROUND: Non‐small‐cell lung cancer (NSCLC) is the leading cause of death from cancer in China. Gefitinib is effective for patients with positive epidermal growth factor receptor gene mutation; however, acquired drug resistance counteracts the duration response. Hyperthermia is widely clinically...
保存先:
| 出版年: | Thorac Cancer |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons Australia, Ltd
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4930961/ https://ncbi.nlm.nih.gov/pubmed/27385984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12346 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|